Azithromycin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 3: | Line 3: | ||
==Development== | ==Development== | ||
Azithromycin was [[patent]]ed in 1982.<ref name="urlpatent:4328334 - Google Patents">{{cite web |url=http://www.google.com/patents?q=patent:4328334 |title=patent:4328334 - Google Patents |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=ZITHROMAX |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Non-authorized [[generic drug]]s manufactured by [http://www.tevapharm.com/ Teva], [http://www.sandoz.com/ Sandoz], and Abraxis were approved in the [[United States]] starting in 2005.<ref name="urlDrugs@ | Azithromycin was [[patent]]ed in 1982.<ref name="urlpatent:4328334 - Google Patents">{{cite web |url=http://www.google.com/patents?q=patent:4328334 |title=patent:4328334 - Google Patents |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=ZITHROMAX |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Non-authorized [[generic drug]]s manufactured by [http://www.tevapharm.com/ Teva], [http://www.sandoz.com/ Sandoz], and Abraxis were approved in the [[United States of America]] starting in 2005.<ref name="urlDrugs@FDA2">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=azithromycin |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> | ||
==Drug toxicity== | ==Drug toxicity== | ||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:01, 15 July 2024
In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellular infections, toxoplasmosis, and cryptosporidiosis."[1]
Development
Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States of America starting in 2005.[4]
Drug toxicity
Drug toxicity includes cardiovascular death.[5]
References
- ↑ Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ patent:4328334 - Google Patents. Retrieved on 2009-02-01.
- ↑ Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01.
- ↑ Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01.
- ↑ Ray et al. (2012) Azithromycin and the Risk of Cardiovascular Death